Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial
- PMID: 16255781
- PMCID: PMC1298328
- DOI: 10.1186/1475-2891-4-30
Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial
Abstract
Background: Osteoporosis is the gradual declining in bone mass with age, leading to increased bone fragility and fractures. Fractures in hip and spine are known to be the most important complication of the disease which leads in the annual mortality rate of 20% and serious morbidity rate of 50%. Menopause is one of the most common risk factors of osteoporosis. After menopause, sex hormone deficiency is associated with increased remodeling rate and negative bone balance, leading to accelerated bone loss and micro-architectural defects, resulting into increased bone fragility. Compounds with estrogen-like biological activity similar to "Isoflavones" present in plants especially soy, may reduce bone loss in postmenopausal women as they are similar in structure to estrogens. This research, therefore, was carried out to study the effects of Iranian soy protein on biochemical indicators of bone metabolism in osteopenic menopausal women.
Materials and methods: This clinical trial of before-after type was carried out on 15 women 45-64 years of age. Subjects were given 35 g soy protein per day for 12 weeks. Blood and urine sampling, anthropometric measurement and 48-h-dietary recalls were carried out at zero, 6 and 12 weeks. Food consumption data were analyzed using Food Proccessor Software. For the study of bone metabolism indicators and changes in anthropometric data as well as dietary intake, and repeated analyses were employed.
Results: Comparison of weight, BMI, physical activity, energy intake and other intervening nutrients did not reveal any significant changes during different stages of the study. Soy protein consumption resulted in a significant reduction in the urinary deoxypyridinoline and increasing of total alkaline phosphatase (p < 0.05), although the alterations in osteocalcin, c-telopeptide, IGFBP3 and type I collagen telopeptide were not significant.
Conclusion: In view of beneficial effect of soy protein on bone metabolism indicators, inclusion of this relatively inexpensive food in the daily diet of menopausal women, will probably delay bone resorption, thereby preventing osteoporosis.
Similar articles
-
Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women.J Clin Endocrinol Metab. 2000 Sep;85(9):3043-8. doi: 10.1210/jcem.85.9.6787. J Clin Endocrinol Metab. 2000. PMID: 10999783 Clinical Trial.
-
[Biochemical markers of bone turnover : clinical usefulness in osteoporosis].Ann Biol Clin (Paris). 1999 Mar-Apr;57(2):137-48. Ann Biol Clin (Paris). 1999. PMID: 10210740 Review. French.
-
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.J Bone Miner Res. 1996 Mar;11(3):337-49. doi: 10.1002/jbmr.5650110307. J Bone Miner Res. 1996. PMID: 8852944
-
Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial.Arch Intern Med. 2011 Aug 8;171(15):1363-9. doi: 10.1001/archinternmed.2011.330. Arch Intern Med. 2011. PMID: 21824950 Clinical Trial.
-
Soy isoflavones for osteoporosis: an evidence-based approach.Maturitas. 2011 Dec;70(4):333-8. doi: 10.1016/j.maturitas.2011.09.001. Epub 2011 Sep 29. Maturitas. 2011. PMID: 21958941 Review.
Cited by
-
Soy proteins and isoflavones affect bone mineral density in older women: a randomized controlled trial.Am J Clin Nutr. 2009 Jul;90(1):234-42. doi: 10.3945/ajcn.2009.27600. Epub 2009 May 27. Am J Clin Nutr. 2009. PMID: 19474141 Free PMC article. Clinical Trial.
-
Functional foods and their role in cancer prevention and health promotion: a comprehensive review.Am J Cancer Res. 2017 Apr 1;7(4):740-769. eCollection 2017. Am J Cancer Res. 2017. PMID: 28469951 Free PMC article. Review.
-
Review of Isoflavones and Their Potential Clinical Impacts on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients.Prev Nutr Food Sci. 2022 Dec 31;27(4):347-353. doi: 10.3746/pnf.2022.27.4.347. Prev Nutr Food Sci. 2022. PMID: 36721750 Free PMC article. Review.
-
The influence of folic acid supplementation on maternal and fetal bone turnover.J Bone Miner Metab. 2011 Mar;29(2):186-92. doi: 10.1007/s00774-010-0205-0. Epub 2010 Jul 3. J Bone Miner Metab. 2011. PMID: 20602129
-
Tackling metabolic syndrome by functional foods.Rev Endocr Metab Disord. 2013 Sep;14(3):287-97. doi: 10.1007/s11154-013-9270-8. Rev Endocr Metab Disord. 2013. PMID: 24057596 Review.
References
-
- Barrett CE. Epidemiology and the menopause:A global overview. Int J Fertil. 1993;38:6–14. - PubMed
-
- Position statement of the north american menopause society Management of postmenopausal osteoporosis. Menopause. 2002;9:84–101. - PubMed
-
- Scharbo DM. Hormone replacement therapy. Nurse Pract. 1996;21:1–13. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous